BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22683612)

  • 21. Validation of measurement scales in ocular graft-versus-host disease.
    Inamoto Y; Chai X; Kurland BF; Cutler C; Flowers ME; Palmer JM; Carpenter PA; Heffernan MJ; Jacobsohn D; Jagasia MH; Pidala J; Khera N; Vogelsang GB; Weisdorf D; Martin PJ; Pavletic SZ; Lee SJ;
    Ophthalmology; 2012 Mar; 119(3):487-93. PubMed ID: 22153706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease.
    Palmer J; Chai X; Pidala J; Inamoto Y; Martin PJ; Storer B; Pusic I; Flowers ME; Arora M; Pavletic SZ; Lee SJ
    Blood; 2016 Jan; 127(1):160-6. PubMed ID: 26527676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: a grading algorithm versus blinded expert panel review.
    Weisdorf DJ; Hurd D; Carter S; Howe C; Jensen LA; Wagner J; Stablein D; Thompson J; Kernan NA
    Biol Blood Marrow Transplant; 2003 Aug; 9(8):512-8. PubMed ID: 12931120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of Patient-Reported Outcomes with Clinical Organ Responses: Data from the Belumosudil Chronic Graft-versus-Host Disease Studies.
    Lee SJ; Cutler C; Blazar BR; Tu A; Yang Z; Pavletic SZ
    Transplant Cell Ther; 2022 Oct; 28(10):700.e1-700.e6. PubMed ID: 35781099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow transplant with post-transplant cyclophosphamide for recessive dystrophic epidermolysis bullosa expands the related donor pool and permits tolerance of nonhaematopoietic cellular grafts.
    Ebens CL; McGrath JA; Tamai K; Hovnanian A; Wagner JE; Riddle MJ; Keene DR; DeFor TE; Tryon R; Chen M; Woodley DT; Hook K; Tolar J
    Br J Dermatol; 2019 Dec; 181(6):1238-1246. PubMed ID: 30843184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of gastrointestinal and hepatic chronic graft-versus-host [corrected] disease manifestations on major outcomes: a chronic graft-versus-host [corrected] disease consortium study.
    Pidala J; Chai X; Kurland BF; Inamoto Y; Flowers ME; Palmer J; Khera N; Jagasia M; Cutler C; Arora M; Vogelsang G; Lee SJ
    Biol Blood Marrow Transplant; 2013 May; 19(5):784-91. PubMed ID: 23395601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracorporeal photophoresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(6):1-82. PubMed ID: 23074497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diverse Activity of IL-17
    Klimczak A; Suchnicki K; Sedzimirska M; Lange A
    Arch Immunol Ther Exp (Warsz); 2019 Oct; 67(5):311-323. PubMed ID: 31177288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease.
    Bhutani D; Dyson G; Manasa R; Deol A; Ratanatharathorn V; Ayash L; Abidi M; Lum LG; Al-Kadhimi Z; Uberti JP
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):159-64. PubMed ID: 25445637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bandage Soft Contact Lenses for Ocular Graft-versus-Host Disease.
    Inamoto Y; Sun YC; Flowers ME; Carpenter PA; Martin PJ; Li P; Wang R; Chai X; Storer BE; Shen TT; Lee SJ
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2002-7. PubMed ID: 26189353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient-reported treatment response in chronic graft-
    Im A; Pusic I; Onstad L; Kitko CL; Hamilton BK; Alousi AM; Flowers ME; Sarantopoulos S; Carpenter P; White J; Arai S; El Jurdi N; Chen G; Cutler C; Lee S; Pidala J
    Haematologica; 2024 Jan; 109(1):143-150. PubMed ID: 37226713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.
    Shulman HM; Sullivan KM; Weiden PL; McDonald GB; Striker GE; Sale GE; Hackman R; Tsoi MS; Storb R; Thomas ED
    Am J Med; 1980 Aug; 69(2):204-17. PubMed ID: 6996481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Motor ability, function, and health-related quality of life as correlates of symptom burden in patients with sclerotic chronic graft-versus-host disease receiving imatinib mesylate.
    Rosenthal EA; Ho PS; Joe GO; Mitchell SA; Booher S; Pavletic SZ; Baird K; Cowen EW; Comis LE
    Support Care Cancer; 2020 Aug; 28(8):3679-3689. PubMed ID: 31811481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Psychological Distress on Quality of Life, Functional Status, and Survival in Patients with Chronic Graft-versus-Host Disease.
    El-Jawahri A; Pidala J; Khera N; Wood WA; Arora M; Carpenter PA; Palmer J; Flowers ME; Jagasia M; Chen YB; Lee SJ
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2285-2292. PubMed ID: 30031937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful use of miniphotopheresis for the treatment of graft-versus-host disease.
    Hackstein H; Amoros JJ; Bein G; Woessmann W
    Transfusion; 2014 Aug; 54(8):2022-7. PubMed ID: 24666366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial.
    Flowers ME; Parker PM; Johnston LJ; Matos AV; Storer B; Bensinger WI; Storb R; Appelbaum FR; Forman SJ; Blume KG; Martin PJ
    Blood; 2002 Jul; 100(2):415-9. PubMed ID: 12091330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corticosteroid-Free Primary Treatment of Chronic Extensive Graft-versus-Host Disease Incorporating Rituximab.
    Solomon SR; Sizemore CA; Ridgeway M; Zhang X; Smith J; Brown S; Holland HK; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2015 Sep; 21(9):1576-82. PubMed ID: 25985915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study.
    Pidala J; Vogelsang G; Martin P; Chai X; Storer B; Pavletic S; Weisdorf DJ; Jagasia M; Cutler C; Palmer J; Jacobsohn D; Arai S; Lee SJ
    Haematologica; 2012 Mar; 97(3):451-8. PubMed ID: 22058206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Less graft-versus-host disease after rabbit antithymocyte globulin conditioning in unrelated bone marrow transplantation for leukemia and myelodysplasia: comparison with matched related bone marrow transplantation.
    Atta EH; de Oliveira DC; Bouzas LF; Nucci M; Abdelhay E
    PLoS One; 2014; 9(9):e107155. PubMed ID: 25188326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.